Stock Events

Stock Events

Amneal Pharmaceuticals 

$17.44
76
-$0.43-2.41% 20:00 Today
+$0.00+0%20:10After hours

Statistics

Day High
17.71
Day Low
17.38
52W High
19.26
52W Low
9.44
Volume
1,426,045
Avg. Volume
2,008,993
Mkt Cap
6.07B
P/E Ratio
46.43
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.12
0.18
0.24
0.3
Expected EPS
0.224355
Actual EPS
N/A

Financials

2.39%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.02BRevenue
72.06MNet Income

Analyst Ratings

21.00Average Price Target
The highest estimate is 25.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMRX. It's not an investment recommendation.
Amazon
17
AMZN
Apple
16
AAPL
AMD
15
AMD
Realty Income
14
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, directly competing with Amneal in the generics market.
Perrigo Company
PRGO
Mkt Cap2.01B
Perrigo Company plc operates in the over-the-counter health and wellness market, competing with Amneal's portfolio of generic and specialty pharmaceutical products.
Dr. Reddy`s Laboratories
RDY
Mkt Cap10.15B
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company that produces and markets a wide range of generic drugs, directly competing with Amneal.
Enact
ACT
Mkt Cap6.75B
Actavis, which was acquired by Allergan, competed in the generics and specialty pharmaceutical markets, similar to Amneal.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the specialty pharmaceutical market, overlapping with some of Amneal's product lines.

About

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Show more...
CEO
Chirag K. Patel
Employees
8500
Country
United States
ISIN
US03168L1052
WKN
000A2JLMD

Listings

STU
DE
2DT.STU
MU
DE
2DT.MU
F
DE
2DT.F
XNAS
US
AMRX

0 Comments

Share your thoughts

FAQ

What is Amneal Pharmaceuticals stock price today?▼
The current price of AMRX is $17.44 USD — it has decreased by -2.41% in the past 24 hours. Watch Amneal Pharmaceuticals stock price performance more closely on the chart.
What is Amneal Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Amneal Pharmaceuticals stocks are traded under the ticker AMRX.
Is Amneal Pharmaceuticals stock price growing?▼
AMRX stock has fallen by -0.57% compared to the previous week, the month change is a -5.63% fall, over the last year Amneal Pharmaceuticals has showed a +82.62% increase.
What is Amneal Pharmaceuticals market cap?▼
Today Amneal Pharmaceuticals has the market capitalization of 6.07B
When is the next Amneal Pharmaceuticals earnings date?▼
Amneal Pharmaceuticals is going to release the next earnings report on October 29, 2026.
What were Amneal Pharmaceuticals earnings last quarter?▼
AMRX earnings for the last quarter are 0.3 USD per share, whereas the estimation was 0.22 USD resulting in a +34.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Amneal Pharmaceuticals revenue for the last year?▼
Amneal Pharmaceuticals revenue for the last year amounts to 3.02B USD.
What is Amneal Pharmaceuticals net income for the last year?▼
AMRX net income for the last year is 72.06M USD.
How many employees does Amneal Pharmaceuticals have?▼
As of September 04, 2026, the company has 8,500 employees.
In which sector is Amneal Pharmaceuticals located?▼
Amneal Pharmaceuticals operates in the Health & Wellness sector.
When did Amneal Pharmaceuticals complete a stock split?▼
The last stock split for Amneal Pharmaceuticals was on August 26, 2013 with a ratio of 1:25.
Where is Amneal Pharmaceuticals headquartered?▼
Amneal Pharmaceuticals is headquartered in Bridgewater, United States.